Opportunity ID: 281932

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-GH-16-008
Funding Opportunity Title: Hospital-based birth defects surveillance in Kampala, Uganda
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 1
Assistance Listings: 93.067 — Global AIDS
Cost Sharing or Matching Requirement: No
Version: Synopsis 3
Posted Date: Mar 02, 2016
Last Updated Date: Mar 03, 2016
Original Closing Date for Applications: May 04, 2016 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date.
Current Closing Date for Applications: May 04, 2016 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date.
Archive Date: Jun 03, 2016
Estimated Total Program Funding: $3,000,000
Award Ceiling: $500,000
Award Floor: $0

Eligibility

Eligible Applicants: Public and State controlled institutions of higher education
Private institutions of higher education
Additional Information on Eligibility:

Additional Information

Agency Name: Centers for Disease Control and Prevention – ERA
Description: The purpose of this project is to: 1) continue a birth defects surveillance system implemented under award #1U01GH000487 in four main hospitals in Kampala, Uganda focusing on major external structural birth defects; and 2) conduct a nested case-control study concurrently with the surveillance to determine if maternal use of cotrimoxazole or ARTs during very early pregnancy is associated with a higher risk of birth defects in newborns. Results from this study will provide background rates of birth defects in Kampala and provide baseline estimates of maternal medication use to treat HIV/AIDS in pregnancy and the prevalence of major external birth defects.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

CDC Technical Information Management Section (TIMS)

Telephone 770-488-2700

ogstims@cdc.gov

Hours: Monday – Friday, 7am – 4:30pm U.S. Eastern Time

Email:ogstims@cdc.gov

Version History

Version Modification Description Updated Date
Updated Contact Information. Mar 03, 2016
Updated contact information. Mar 03, 2016
Mar 03, 2016

DISPLAYING: Synopsis 3

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-GH-16-008
Funding Opportunity Title: Hospital-based birth defects surveillance in Kampala, Uganda
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 1
Assistance Listings: 93.067 — Global AIDS
Cost Sharing or Matching Requirement: No
Version: Synopsis 3
Posted Date: Mar 02, 2016
Last Updated Date: Mar 03, 2016
Original Closing Date for Applications: May 04, 2016 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date.
Current Closing Date for Applications: May 04, 2016 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date.
Archive Date: Jun 03, 2016
Estimated Total Program Funding: $3,000,000
Award Ceiling: $500,000
Award Floor: $0

Eligibility

Eligible Applicants: Public and State controlled institutions of higher education
Private institutions of higher education
Additional Information on Eligibility:

Additional Information

Agency Name: Centers for Disease Control and Prevention – ERA
Description: The purpose of this project is to: 1) continue a birth defects surveillance system implemented under award #1U01GH000487 in four main hospitals in Kampala, Uganda focusing on major external structural birth defects; and 2) conduct a nested case-control study concurrently with the surveillance to determine if maternal use of cotrimoxazole or ARTs during very early pregnancy is associated with a higher risk of birth defects in newborns. Results from this study will provide background rates of birth defects in Kampala and provide baseline estimates of maternal medication use to treat HIV/AIDS in pregnancy and the prevalence of major external birth defects.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

CDC Technical Information Management Section (TIMS)

Telephone 770-488-2700

ogstims@cdc.gov

Hours: Monday – Friday, 7am – 4:30pm U.S. Eastern Time

Email:ogstims@cdc.gov

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-GH-16-008
Funding Opportunity Title: Hospital-based birth defects surveillance in Kampala, Uganda
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 1
Assistance Listings: 93.067 — Global AIDS
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Mar 03, 2016
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: May 04, 2016 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date.
Archive Date: Jun 03, 2016
Estimated Total Program Funding: $3,000,000
Award Ceiling: $500,000
Award Floor: $0

Eligibility

Eligible Applicants: Public and State controlled institutions of higher education
Private institutions of higher education
Additional Information on Eligibility:

Additional Information

Agency Name: Centers for Disease Control and Prevention – ERA
Description: The purpose of this project is to: 1) continue a birth defects surveillance system implemented under award #1U01GH000487 in four main hospitals in Kampala, Uganda focusing on major external structural birth defects; and 2) conduct a nested case-control study concurrently with the surveillance to determine if maternal use of cotrimoxazole or ARTs during very early pregnancy is associated with a higher risk of birth defects in newborns. Results from this study will provide background rates of birth defects in Kampala and provide baseline estimates of maternal medication use to treat HIV/AIDS in pregnancy and the prevalence of major external birth defects.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

CDC Technical Information Management Section (TIMS)

Telephone 770-488-2700

Hours: Monday – Friday, 7am – 4:30pm U.S. Eastern Time

Email:ogstims@cdc.gov

DISPLAYING: Synopsis 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-GH-16-008
Funding Opportunity Title: Hospital-based birth defects surveillance in Kampala, Uganda
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 1
Assistance Listings: 93.067 — Global AIDS
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Mar 03, 2016
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: May 04, 2016 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date.
Archive Date: Jun 03, 2016
Estimated Total Program Funding: $3,000,000
Award Ceiling: $500,000
Award Floor: $0

Eligibility

Eligible Applicants: Public and State controlled institutions of higher education
Private institutions of higher education
Additional Information on Eligibility:

Additional Information

Agency Name: Centers for Disease Control and Prevention – ERA
Description: The purpose of this project is to: 1) continue a birth defects surveillance system implemented under award #1U01GH000487 in four main hospitals in Kampala, Uganda focusing on major external structural birth defects; and 2) conduct a nested case-control study concurrently with the surveillance to determine if maternal use of cotrimoxazole or ARTs during very early pregnancy is associated with a higher risk of birth defects in newborns. Results from this study will provide background rates of birth defects in Kampala and provide baseline estimates of maternal medication use to treat HIV/AIDS in pregnancy and the prevalence of major external birth defects.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Sharon Campolucci
ssc1@cdc.gov

Email:ssc1@cdc.gov

Folder 281932 Full Announcement-CDC-RFA-GH16-008 -> cdc-rfa-gh16-008.pdf

Packages

Agency Contact Information: CDC Technical Information Management Section (TIMS)
Telephone 770-488-2700
ogstims@cdc.gov

Hours: Monday – Friday, 7am – 4:30pm U.S. Eastern Time

Email: ogstims@cdc.gov

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
93.067 RFA-GH-16-008 Hospital-based birth defects surveillance in Kampala, Uganda PKG00221290 Mar 02, 2016 May 04, 2016 View

Package 1

Mandatory forms

281932 RR_SF424_2_0-2.0.pdf

281932 PHS398_CoverPageSupplement_2_0-2.0.pdf

281932 PerformanceSite_2_0-2.0.pdf

281932 RR_OtherProjectInfo_1_3-1.3.pdf

281932 RR_KeyPersonExpanded_2_0-2.0.pdf

281932 PHS398_ResearchPlan_2_0-2.0.pdf

Optional forms

281932 PHS398_CumulativeInclusionReport-1.0.pdf

281932 PlannedReport-1.0.pdf

281932 RR_SubawardBudget30_1_3-1.3.pdf

281932 PHS398_ModularBudget_1_2-1.2.pdf

281932 RR_Budget_1_3-1.3.pdf

2025-07-09T10:03:47-05:00

Share This Post, Choose Your Platform!

About the Author: